China Biotech Services Holdings Limited

SEHK:8037 Rapport sur les actions

Capitalisation boursière : HK$429.3m

China Biotech Services Holdings Gestion

Gestion contrôle des critères 2/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur généralno data
Propriété du PDGn/a
Durée moyenne d'occupation des postes de direction4.2yrs
Durée moyenne du mandat des membres du conseil d'administration6.9yrs

Mises à jour récentes de la gestion

Recent updates

China Biotech Services Holdings Limited's (HKG:8037) 28% Share Price Plunge Could Signal Some Risk

Aug 12
China Biotech Services Holdings Limited's (HKG:8037) 28% Share Price Plunge Could Signal Some Risk

Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio

Jun 26
Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio

China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%

Mar 07
China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%

Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%

Jan 18
Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%

We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger

Jan 06
We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger

Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?

Dec 09
Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?

These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely

Aug 24
These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely

A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)

Nov 05
A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)

Is China Biotech Services Holdings (HKG:8037) A Risky Investment?

Oct 13
Is China Biotech Services Holdings (HKG:8037) A Risky Investment?

What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You

Jun 28
What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You

China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger

Mar 16
China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger

China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively

Dec 01
China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively

Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive

Jul 26
Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive

China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors

Apr 05
China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors

Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital

Mar 23
Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital

Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?

Feb 23
Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?

Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)

Jan 28
Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)

What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?

Jan 11
What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?

The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested

Dec 08
The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested

PDG

China Biotech Services Holdings n'a pas de PDG, ou nous n'avons pas de données sur eux.


Équipe de direction

NomPositionTitularisationCompensationPropriété
Xiaolin Liu
Executive Chairman & Compliance Officer7.3yrsHK$5.01m54.38%
HK$ 233.5m
Song Huang
CTO & Executive Director4.9yrsHK$580.00kpas de données
Xun He
Executive Directorno dataHK$1.06m0%
HK$ 0
Xuanming Yang
Chief Scientific Officerno datapas de donnéespas de données
Yi Yao
Consultant3.5yrsHK$1.70mpas de données
Miu Shun Wong
Company Secretary7.1yrspas de donnéespas de données

4.2yrs

Durée moyenne de l'emploi

57yo

Âge moyen

Gestion expérimentée: L'équipe de direction de 8037 est considérée comme expérimentée (ancienneté moyenne 4.2 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Xiaolin Liu
Executive Chairman & Compliance Officer7.3yrsHK$5.01m54.38%
HK$ 233.5m
Song Huang
CTO & Executive Director7.2yrsHK$580.00kpas de données
Xun He
Executive Director6.3yrsHK$1.06m0%
HK$ 0
Ting Yuk Wu
Member of Scientific Advisory Boardno datapas de donnéespas de données
Guoxiang Yan
Independent Non-Executive Director7.3yrsHK$240.00kpas de données
Hongji Qian
Independent Non-Executive Director6.7yrsHK$240.00kpas de données
Gang Song
Member of Scientific Advisory Boardno datapas de donnéespas de données
Paul Waring
Member of Scientific Advisory Boardno datapas de donnéespas de données
Yang Xin Fu
Chairman of Scientific Advisory Boardno datapas de donnéespas de données
Yao Shiego
Member of Scientific Advisory Boardno datapas de donnéespas de données
Shengli Bi
Member of Scientific Advisory Boardno datapas de donnéespas de données
Yuantao Guo
Independent Non Executive Directorless than a yearpas de donnéespas de données

6.9yrs

Durée moyenne de l'emploi

55.5yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de 8037 sont considérés comme expérimentés (ancienneté moyenne 6.9 ans).